103 results on '"Nathan, Robert"'
Search Results
2. The role of Medical Officers of Health in Civil Defence and how they influenced modern emergency medical practice
3. The impact of Covid-19 and Russia–Ukraine war on the financial asset volatility: Evidence from equity, cryptocurrency and alternative assets
4. The role of Medical Officers of Health in Civil Defence and how they influenced modern emergency medical practice
5. Covid-19 pandemic, asset prices, risks, and their convergence: A survey of Islamic and G7 stock market, and alternative assets
6. Fintech Adoption Drivers for Innovation for SMEs in Indonesia
7. Phase change thermal storage: Cooking with more power and versatility
8. CAPTAIN: EFFECTS OF AGE AS A CONTINUOUS VARIABLE ON TREATMENT OUTCOMES
9. CAPTAIN: EFFECTS OF AGE OF ASTHMA ONSET AS A CONTINUOUS VARIABLE ON TREATMENT OUTCOMES
10. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
11. User Innovativeness and Fintech Adoption in Indonesia
12. Phase change thermal storage: Cooking with more power and versatility
13. CAPTAIN: Effects of Cardiovascular Risk on Response to Triple Therapy in Patients With Inadequately Controlled Asthma on Inhaled Corticosteroids/Long-acting β2-agonists (ICS/LABA)
14. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
15. CAPTAIN STUDY: EFFECT OF BASELINE LUNG FUNCTION ON RESPONSE TO TRIPLE THERAPY IN PATIENTS WITH ASTHMA INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID/LONG-ACTING BETA2-AGONIST THERAPY
16. CAPTAIN STUDY: ASSOCIATION OF MODERATE AND SEVERE ASTHMA EXACERBATIONS WITH LUNG FUNCTION AND PATIENT-REPORTED OUTCOMES IN A LARGE RANDOMIZED PHASE III CLINICAL TRIAL
17. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy
18. Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI in inadequately controlled asthma: the CAPTAIN study
19. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial
20. Use of ultrasound and mHealth to improve perinatal outcomes in low and middle income countries
21. Including ultrasound scans in antenatal care in low-resource settings: Considering the complementarity of obstetric ultrasound screening and maternity waiting homes in strengthening referral systems in low-resource, rural settings
22. Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate
23. Application of Guideline-Based Definition of Severe Asthma Exacerbation with Objective and Subjective Methods to Evaluate Sensitivity on Treatment Response in a Randomized Controlled Trial
24. Factors Influencing Consumer Behavior and Prospective Purchase Decisions in a Dynamic Pricing Environment — An Exploratory Factor Analysis Approach
25. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
26. Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors
27. Evaluation of Focused Obstetric Ultrasound Examinations by Health Care Personnel in the Democratic Republic of Congo, Guatemala, Kenya, Pakistan, and Zambia
28. Ovarian regulation of foraging division of labour in Africanized backcross and pollen-hoarding honeybees
29. Evaluation of Focused Obstetric Ultrasound Examinations by Health Care Personnel in the Democratic Republic of Congo, Guatemala, Kenya, Pakistan, and Zambia
30. 3: Routine antenatal ultrasound in low/middle income countries: a cluster randomized trial
31. ACR BI-RADS Use in Low-Income Countries: An Analysis of Diagnostic Breast Ultrasound Practice in Uganda
32. Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States
33. Impact of Point-of-Care Ultrasound Training on Surgical Residents’ Confidence
34. Allergic Rhinitis Patient Factors Associated with Allergen Immunotherapy Treatment Persistence
35. Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis
36. Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol 320 μg Provides 24-Hour Nasal Symptom Relief in Patients with Seasonal Allergic Rhinitis
37. Associations of patient outcomes with level of asthma control
38. The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States
39. 187 Reduction in Asthma Deteriorations in Subjects with Persistent Asthma not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids
40. 190 Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects With Persistent Asthma
41. 191 Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol
42. Awareness of and Adherence to National Asthma Education and Prevention Program (NAEPP) Guidelines by Asthma Care Specialists and Primary Care Physicians: Comparison of Results From the 2009 Asthma Insight and Management (AIM) and 1998 Asthma in America (AIA) Surveys
43. Mometasone Furoate/Formoterol Improves Asthma Control in Subjects With Uncontrolled Persistent Asthma
44. The Effect of Mometasone Furoate/Formoterol Combination Treatment on Severe Exacerbations Requiring Hospitalization, Emergency Treatment, or Systemic Corticosteroid Treatment: Results From Two Randomized, Placebo-Controlled Studies
45. Low-, Medium-, and High-Dose Mometasone Furoate/Formoterol Improves Lung Function in Persistent Asthmatics
46. The Asthma Insight and Management (AIM) Survey of Differences in Health Among Patients With Asthma and the General Population: Evidence of the Burden of Asthma
47. Treatment of Persistent Asthma With Mometasone Furoate/Formoterol Combination Therapy Is Associated With a Low Incidence of Oral Candidiasis and Dysphonia
48. Mometasone Furoate/Formoterol Combination Therapy Reduces Nocturnal Awakenings in Patients With Moderate or Severe Asthma
49. Differences in the Understanding of Asthma Terminology Among Patients and Physicians Interviewed in the Asthma Insight and Management (AIM) Survey
50. Quality of Life Is Improved in Persistent Asthma Subjects Treated With Mometasone Furoate/Formoterol: A New Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.